Skip to content
Screener

R&D at other companies

Baxter International logo
Baxter InternationalBAX
$139M-0.7%
Revvity logo
RevvityRVTY
$57.89M+8.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.65B+3.9%
Utah Medical Products logo
Utah Medical ProductsUTMD
$154K+14.1%
Medtronic logo
MedtronicMDT
$671M-1.9%
Organon logo
OrganonOGN
$93M-3.1%

Segments

By segment

See full
CooperVision$22.1M-13.7%
CooperSurgical$20.4M+2.5%

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$14.6B+7.4%
Enterprise value$17.52B+9.5%
P/E61.9×+28.6×
P/S3.5×+0.1×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.

Filed
Jun 5, 2026, 4:47 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-041305
Line itemThree Months / 2026Three Months / 2025Six Months / 2026Six Months / 2025
Cost of sales346.1323.2675.0627.7
Gross profit735.4679.11,430.61,339.3
Selling, general and administrative expense676.2399.01,066.4786.9
Research and development expense42.545.586.886.2
Amortization of intangibles47.749.895.699.4
Operating income (loss)(31.0)184.8181.8366.8
Interest expense20.924.243.350.2
Other (income) expense, net(3.5)16.1(5.3)18.8

Item 1. Unaudited Financial Statements

FAQ

What is The Cooper Companies, Inc.'s R&D?
The Cooper Companies, Inc. (COO) reported R&D of $42.5M in Q1 2026.
How has The Cooper Companies, Inc.'s R&D changed year-over-year?
The Cooper Companies, Inc.'s R&D decreased by 6.6% year-over-year, from $45.5M to $42.5M.
What is the long-term trend for The Cooper Companies, Inc.'s R&D?
Over 4 years (2021 to 2025), The Cooper Companies, Inc.'s R&D has grown at a 16.7% compound annual growth rate (CAGR), from $92.9M to $172.2M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about The Cooper Companies, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude